The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Polypill Strategy in Secondary Cardiovascular Prevention
Open accessAbstract
BACKGROUND: A polypill that includes key medications associated with improved outcomes (aspirin, angiotensin-converting-enzyme [ACE] inhibitor, and statin) has been proposed as a simple approach to the secondary prevention of cardiovascular death and complications after myocardial infarction. METHODS: In this phase 3, randomized, controlled clinical trial, we assigned patients with myocardial infarction within the previous 6 months to a polypill-based strategy or usual care. The polypill treatment consisted of aspirin (100 mg), ramipril (2.5, 5, or 10 mg), and atorvastatin (20 or 40 mg). The primary composite outcome was cardiovascular death, nonfatal type 1 myocardial infarction, nonfatal ischemic stroke, or urgent revascularization. The key secondary end point was a composite of cardiovascular death, nonfatal type 1 myocardial infarction, or nonfatal ischemic stroke. RESULTS: A total of 2499 patients underwent randomization and were followed for a median of 36 months. A primary-outcome event occurred in 118 of 1237 patients (9.5%) in the polypill group and in 156 of 1229 (12.7%) in the usual-care group (hazard ratio, 0.76; 95% confidence interval [CI], 0.60 to 0.96; P = 0.02). A key secondary-outcome event occurred in 101 patients (8.2%) in the polypill group and in 144 (11.7%) in the usual-care group (hazard ratio, 0.70; 95% CI, 0.54 to 0.90; P = 0.005). The results were consistent across prespecified subgroups. Medication adherence as reported by the patients was higher in the polypill group than in the usual-care group. Adverse events were similar between groups. CONCLUSIONS: Treatment with a polypill containing aspirin, ramipril, and atorvastatin within 6 months after myocardial infarction resulted in a significantly lower risk of major adverse cardiovascular events than usual care. (Funded by the European Union Horizon 2020; SECURE ClinicalTrials.gov number, NCT02596126; EudraCT number, 2015-002868-17.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Particularly in the field of T2DM, studies have shown benefits of a stepwise approach to intensify treatment, and it appears that attaining treatment goals is similar, side effects are fewer, and patient satisfaction is significantly higher with such an approach.369,370”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [369]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ibanez, B., James, S., Agewall, S., Antunes, M. J., Bucciarelli-Ducci, C., Bueno, H., Caforio, A. L. P., Crea, F., Goudevenos, J. A., Halvorsen, S., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx393 · Cited by 9,728
Self-citationRoth, G. A., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32203-7 · Cited by 8,600
Self-citation2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Visseren, F. L. J., Mach, F., Smulders, Y. M., Carballo, D., Koskinas, K. C., Bäck, M., Benetos, A., Biffi, A., Boavida, J.-M., Capodanno, D., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab484 · Cited by 6,485
Self-citationHeart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Alonso, A., Beaton, A. Z., Bittencourt, M. S., Boehme, A. K., Buxton, A. E., Carson, A. P., Commodore-Mensah, Y., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001052 · Cited by 5,987
Collet, J.-P., Thiele, H., Barbato, E., Barthélémy, O., Bauersachs, J., Bhatt, D. L., Dendale, P., Dorobantu, M., Edvardsen, T., Folliguet, T., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa575 · Cited by 5,037
Self-citationNaghavi, M., Abajobir, A. A., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abera, S. F., Aboyans, V., Adetokunboh, O., Afshin, A., Agrawal, A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32152-9 · Cited by 4,821
Self-citationFourth Universal Definition of Myocardial Infarction (2018)
Thygesen, K. A., Alpert, J. S., Jaffe, A. S., CHAITMAN, B. R., Bax, J. J., Morrow, D. A., & White, H. D. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.08.1038 · Cited by 4,238
Kyu, H. H., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32335-3 · Cited by 4,192
Pleiotropic Effects of Statins on the Cardiovascular System
Oesterle, A., Laufs, U., & Liao, J. K. (2017) · Circulation Research · doi:10.1161/circresaha.116.308537 · Cited by 1,247
Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences
Chowdhury, R., Khan, H., Heydon, E., Shroufi, A., Fahimi, S., Moore, C., Stricker, B., Mendis, S., Hofman, A., Mant, J., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht295 · Cited by 931
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–333 of 333
Panacea: Polypill Approach to Addressing Heart Failure
Ho, M., & Shore, S. (2026) · Circulation Population Health and Outcomes · doi:10.1161/circoutcomes.125.013151
SEA 2026 Standards for Global Control of Vascular Risk
Mostaza, J. M., Pintó, X., Armario, P., Guijarro, C., Masana, L., Real, J. T., Arrobas-Velilla, T., Baeza‐Trinidad, R., Calmarza, P., Cebollada, J., et al. (2026) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2026.500889
Portela, B. M., Shan, R. M., Miriyapalli, L., Pasupuleti, V., Diaz‐Arocutipa, C., & Hernández, A. V. (2026) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2026.106775
The polypill after acute coronary syndrome: A feasible pill to swallow?
Khan, S. U., & PATEL, K. (2026) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2026.101500
Teng, T.-Q., Bai, L.-L., Liu, J., Wang, M.-M., Sun, G.-X., Yu, Z.-Y., Liu, Z.-S., Xu, J.-C., Jiao, Q.-Y., Wang, Z., et al. (2026) · Lipids in Health and Disease · doi:10.1186/s12944-026-02921-6
Ouma, R. B. O., Ngari, S. M., & Kibet, J. K. (2026) · Health Science Reports · doi:10.1002/hsr2.72117
Cosı́n-Sales, J., Ruíz, R. C., Guerra, L. C., Vivas, D., Alonso, V. B., Doncel-Vecino, L. J., del Egido, A. G., Muñoz‐Rivas, N., Sampio, P. P., Pérez, P. J., et al. (2026) · REC CardioClinics · doi:10.1016/j.rccl.2026.03.001
Self-citationMirhosseini, S. A., Azami, P., Mirzaei, A., Zooravar, D., Yaghoobi, N., Arman, A., Ranjbar, M., Hosseinpour, A., Shams, F., Elhagh, A., et al. (2026) · Cardiology in Review · doi:10.1097/crd.0000000000001251 · Cited by 1
Overpowered by uncontrolled hypertension: can we win this war?
Todua, I., & Salem, D. N. (2026) · Journal of Hypertension · doi:10.1097/hjh.0000000000004307
Cai, H., & Lin, Y. (2026) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-026-04160-3
Особливості призначення поліпілу Триномія® у пацієнтів різного віку
О.A., К., & Romanenko, S. (2026) · Український медичний часопис · doi:10.32471/umj.1680-3051.276641
Гаранин, А. А., Aidumova, O. Y., & Rubanenko, A. O. (2026) · Current Pharmaceutical Design · doi:10.2174/0113816128456490260326073746
Особливості призначення поліпілу Триномія® у пацієнтів різного віку
(2026) · Український медичний часопис · doi:10.32471/umj.1680-3051.274929
Waßmann, S., Weisser, B., Wilke, T., Mevius, A., Randerath, O., & Predel, H. (2026) · Clinical Research in Cardiology · doi:10.1007/s00392-026-02952-0
Li, S. N., Gao, Y. N., Zhu, C.-G., & Li, J. (2026) · Drugs · doi:10.1007/s40265-026-02348-4
Gilyarevskiy, S. R., Golshmid, M. V., & Shchedrina, A. Y. (2026) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2026-213
Hoffmann, U. (2026) · Die Nephrologie · doi:10.1007/s11560-026-00939-6
Stopping β-blockers long after myocardial infarction
Ibáñez, B. (2026) · The Lancet · doi:10.1016/s0140-6736(26)01650-8
Pedicino, D., & Volpe, M. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag683
SMuRF-less, not risk-less: persistence matters after STEMI
Ruscica, M., & Doehner, W. (2026) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwag445
Self-citationLiao, R., Zhang, S., Zhou, Q., Wang, J., Huang, M., Wang, D., & Zhang, H. (2026) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-026-02224-x
Hernández-González, M. A., Fernández-Hernández, J. P., Borrayo–Sánchez, G., Solorio, S., Cruz-Aceves, I., Alfonzo, L. C. B., González, M. A. H., Hernández, J. P. F., Borrayo–Sánchez, G., Meza, S. E. S., et al. (2026) · Archives of Medical Research · doi:10.1016/j.arcmed.2026.103520
Preliminary results of active surveillance in localized prostate cancer GG1
Pozharytski, А. М., Poddubny, Y. A., Parmon, M. L., Suslov, L. N., Ryabcheuski, A. N., Polyakov, S. L., Krasny, S. A., & Rolevich, A. I. (2026) · Cancer Urology · doi:10.17650/1726-9776-2026-22-2-15-25
A Recipe for Estimating the Global Burden of Heart Failure
Joseph, P., & Bartolini, I. J. (2026) · JAMA Cardiology · doi:10.1001/jamacardio.2026.4084
A Polypill Strategy to Close the Heart Failure Treatment Gap
Fonarow, G. C., & McMurray, J. J. V. (2026) · JAMA Cardiology · doi:10.1001/jamacardio.2026.3727
Zheng, Y., Qin, G., Li, Z., Zhu, X., Shi, H., & Zhang, F. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1932608
Montoya-Pérez, J. E., Serna-Garza, J. R., & Gracia‐Ramos, A. E. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1941915
The polypill: the unmet need and great hope for heart failure patients
Biegus, J., Böhm, M., Butler, J., & Piotr, P. (2026) · European Journal of Heart Failure · doi:10.1093/ejhf/xuag324
Cosı́n-Sales, J., Campuzano, R., Cequier, A. R., Díez‐Villanueva, P., Aldomà-Balasch, A., Arrarte, V., López-Sánchez, E. S., Gómez-Pajuelo, C., Fernández‐Friera, L., Chopo-Alcubilla, J. M., et al. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15207916
Living longer but not healthier: Global differences in longevity and cardiometabolic health
Jabbar, A. B. A., Ahmed, S., Hyder, A., Sheikh, S., Deo, S. V., Bhatti, S., Kalra, D. K., Sahebkar, A., Samad, Z. Z., Mishra, S. R., et al. (2026) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2026.10.007
Chia, J. E., Lee, E., Iglesias, J. I., & Ang, S. P. (2026) · Current Cardiology Reports · doi:10.1007/s11886-026-02430-z
Sowan, W., Masarwe, S., Qais-Rabea, A., Jammal-Abboud, R., Rayan‐Gharra, N., Baziliansky, S., & Grosman‐Rimon, L. (2026) · Psychology Health & Medicine · doi:10.1080/13548506.2026.2747941
Alshehri, A. A., Alkhrayef, M. N., Alzaidi, R., Tawfik, Y. M. K., Aldossary, A. M., Altammami, M. A., Alradwan, I. A., Altaf, M. M., Almughem, F. A., Majrashi, M. A., et al. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1837691
Metadata
- Authors
- Castellano, J. M., Pocock, S. J., Bhatt, D. L., Quesada, A. J., Owen, R., Fernandez-Ortiz, A., Sanchez, P. L., Marin Ortuño, F., Vazquez Rodriguez, J. M., Domingo-Fernández, A., Lozano, I., Roncaglioni, M. C., Baviera, M., Foresta, A., Ojeda-Fernandez, L., Colivicchi, F., Di Fusco, S. A., Doehner, W., Meyer, A., Schiele, F., Ecarnot, F., Linhart, A., Lubanda, J.-C., Barczi, G., Merkely, B., Ponikowski, P., Kasprzak, M., Fernandez Alvira, J. M., Andres, V., Bueno, H., Collier, T., Van de Werf, F., Perel, P., Rodriguez-Manero, M., Alonso Garcia, A., Proietti, M., Schoos, M. M., Simon, T., Fernandez Ferro, J., Lopez, N., Beghi, E., Bejot, Y., Vivas, D., Cordero, A., Ibañez, B., & Fuster, V.
- Affiliations
- Spanish National Centre for Cardiovascular Research (ES)
- Brigham and Women's Hospital (US)
- Hospital Clínico San Carlos (ES)
- From Centro Nacional de Investigaciones Cardiovasculares (J.M.C., S.J.P., A.J.Q., A.F.-O., J.M.F.A., V.A., H.B., J.F.F., B.I., V.F.), Centro Integral de Enfermedades Cardiovasculares, Hospital Universitario Monteprincipe, Grupo HM Hospitales (J.M.C.), Hospital Clínico San Carlos, Universidad Complutense (A.F.-O., D.V.), Centro de Investigacion Biomedica en Red de Enfermedades Cardiovasculares (A.F.-O., P.L.S., F.M.O., J.M.V.R., V.A., H.B., A.C., B.I.), Unidad de Investigación Clínica y Ensayos Clínicos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (A.D.-F.), Health Research Institute, October 12 Hospital (H.B.), Fundación Jiménez Díaz University Hospital (J.F.F., B.I.), and Universidad Autonóma de Madrid (J.F.F.), Madrid, the Department of Cardiology, Hospital Universitario Salamanca, Salamanca (P.L.S.), Servicio de Cardiología, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia (F.M.O.), Servicio de Cardiología, Hospital Universitario A Coruña, Instituto de Investigación ...
- Charles University (CZ)
- University of Wrocław (PL)
- University of Liverpool (GB)
- ORCID
- Castellano, Jose M.
- Pocock, Stuart J.
- Bhatt, Deepak L.
- Quesada, Antonio J.
- Owen, Ruth
- Sanchez, Pedro L.
- Lozano, Iñigo
- Roncaglioni, Maria C.
- Baviera, Marta
- Foresta, Andreana
- Colivicchi, Furio
- Doehner, Wolfram
- Meyer, Antje
- Schiele, François
- Ecarnot, Fiona
- Linhart, Aleš
- Lubanda, Jean-Claude
- Ponikowski, Piotr
- Kasprzak, Marta
- Collier, Timothy
- Perel, Pablo
- Proietti, Marco
- Schoos, Mikkel M.
- Simon, Tabassome
- Beghi, Ettore
- Vivas, David
- Cordero, Alberto
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2022-09-15
- Volume
- 387
- Issue
- 11
- Pages
- 967-977
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4293176633
- Cited by
- 334
- References
- 28
- Citations by year
- 2026: 53 · 2025: 68 · 2024: 88 · 2023: 100 · 2022: 25
- FWCI
- 48.92
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Lirias (KU Leuven) (submittedVersion)
- Funders
- European Union Horizon (633765)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- polypill, secondary prevention of cardiovascular disease, myocardial infarction, aspirin, ramipril, atorvastatin, ACE inhibitors, statins, major adverse cardiovascular events, ischemic stroke, revascularization, medication adherence, combination therapy, secondary prevention after myocardial infarction, usual care comparison, cardiovascular mortality, urgent revascularization
- MeSH terms
- Atorvastatin, Ischemic Stroke, Angiotensin-Converting Enzyme Inhibitors, Aspirin, Cardiovascular Diseases, Humans, Myocardial Infarction, Platelet Aggregation Inhibitors, Ramipril, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
